These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6152198)
1. Neurotransmitters and neurodegenerative disorders. Kanazawa I Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198 [TBL] [Abstract][Full Text] [Related]
2. Neurochemical anatomy of movement disorders. Young AB; Penney JB Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481 [TBL] [Abstract][Full Text] [Related]
3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242 [TBL] [Abstract][Full Text] [Related]
4. [GABA and diseases of the extrapyramidal system]. Carrieri P Acta Neurol (Napoli); 1977; 32(5):697-704. PubMed ID: 22223 [No Abstract] [Full Text] [Related]
5. Role of excitotoxins in heredito-degenerative neurologic diseases. Young AB Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Jenner P Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302 [TBL] [Abstract][Full Text] [Related]
12. [Changes in brain level of neurotransmitters]. Kanazawa I Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1148-52. PubMed ID: 1680945 [No Abstract] [Full Text] [Related]
13. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain. Walsh FX; Bird ED; Stevens TJ Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949 [No Abstract] [Full Text] [Related]
14. Biomarkers in Huntington's and Parkinson's Disease. O'Keeffe GC; Michell AW; Barker RA Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264 [TBL] [Abstract][Full Text] [Related]
16. Error processing in normal aging and in basal ganglia disorders. Beste C; Willemssen R; Saft C; Falkenstein M Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908 [TBL] [Abstract][Full Text] [Related]
17. BAC to degeneration bacterial artificial chromosome (BAC)-mediated transgenesis for modeling basal ganglia neurodegenerative disorders. Lu XH Int Rev Neurobiol; 2009; 89():37-56. PubMed ID: 19900614 [TBL] [Abstract][Full Text] [Related]
18. [Neurotransmitters in Huntington chorea (review)]. Barkhatova VP; Larskiĭ EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405 [No Abstract] [Full Text] [Related]
19. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications. Constantinidis J; Bouras C; Richard J Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657 [TBL] [Abstract][Full Text] [Related]
20. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Outeiro TF; Giorgini F Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]